[Sar9] Substance P

[Sar9] Substance P is a synthetic peptide analog derived from the neuropeptide Substance P, distinguished by the substitution of sarcosine at the ninth amino acid position. This modification imparts enhanced metabolic stability and altered receptor binding characteristics, making [Sar9] Substance P a valuable tool in neuropharmacological and receptor signaling research. As a member of the tachykinin peptide family, it plays a significant role in the study of neuropeptide-receptor interactions, signal transduction pathways, and the functional dissection of substance P-mediated biological processes. Its unique structure allows researchers to probe the specificity and dynamics of neurokinin receptors, particularly in contexts where the native ligand is rapidly degraded or exhibits less selectivity.

Receptor pharmacology: [Sar9] Substance P is widely employed in the investigation of neurokinin-1 (NK1) receptor pharmacology due to its enhanced resistance to enzymatic degradation compared to the native peptide. The sarcosine substitution at position 9 modulates its affinity and efficacy at tachykinin receptors, enabling detailed studies of receptor-ligand interactions, agonist selectivity, and downstream signaling events. Researchers utilize this analog to characterize the binding profiles of NK1 and related receptors, facilitating the development of more selective receptor ligands and antagonists.

Signal transduction studies: The peptide's structural stability makes it an ideal probe for dissecting signal transduction mechanisms initiated by tachykinin receptors. By providing sustained receptor activation, [Sar9] Substance P allows for precise analysis of intracellular pathways such as phospholipase C activation, inositol phosphate turnover, and calcium mobilization. These studies are critical for elucidating the molecular basis of neuropeptide-induced cellular responses in both neuronal and non-neuronal systems.

Peptide structure-activity relationship (SAR) analysis: The modified sequence of [Sar9] Substance P serves as a model for evaluating the structure-activity relationships of tachykinin peptides. Researchers employ this analog to systematically assess how specific amino acid substitutions influence receptor binding, activation potency, and biological activity. Such investigations contribute to the rational design of novel peptide analogs with tailored pharmacological properties for research applications.

Neurochemical mapping: Owing to its distinct receptor interaction profile, [Sar9] Substance P is used in neurochemical mapping studies to delineate the distribution and functional relevance of tachykinin receptors in various tissues and organ systems. The analog's stability and selectivity make it suitable for in vitro and ex vivo assays, enabling researchers to localize receptor populations and quantify receptor-mediated responses with improved accuracy.

Peptide-based assay development: The enhanced properties of [Sar9] Substance P support its use in the development and optimization of peptide-based assays. Its resistance to enzymatic breakdown and consistent receptor activity allow for reliable calibration standards and positive controls in receptor binding assays, high-throughput screening platforms, and functional bioassays. These applications are essential for advancing neuropeptide research and for validating the specificity and sensitivity of experimental systems targeting tachykinin pathways.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation